Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-108172
Filing Date
2025-08-13
Accepted
2025-08-13 17:25:48
Documents
79
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20250630.htm   iXBRL 10-Q 2721412
2 EX-31.1 aplt-ex31_1.htm EX-31.1 18802
3 EX-31.2 aplt-ex31_2.htm EX-31.2 21323
4 EX-32.1 aplt-ex32_1.htm EX-32.1 11190
5 EX-32.2 aplt-ex32_2.htm EX-32.2 10410
  Complete submission text file 0000950170-25-108172.txt   9939213

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20250630.xsd EX-101.SCH 1363139
81 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20250630_htm.xml XML 1665964
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 251213076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)